SEARCH

SEARCH BY CITATION

References

  • Adami A, Cavazzoni V. 1999. Occurrence of selected bacterial groups in the feces of piglets fed with Bacillus coagulans as probiotic. J Basic Microbiol 39: 39.
  • Adams MR, Marteau P. 1995. On the safety of lacticacid bacteria from food. Intl J Food Microbiol 27: 263.
  • Andersson A, Granum PE, Ronner U. 1998. The adhesion of Bacillus cereus spores to epithelial cells might be an additional virulence mechanism. Intl J Food Microbiol 39: 939.
  • Ash C, Farrow JAE, Wallbanks S, Collins MD. 1991. Phylogenetic heterogeneity of the genus Bacillus revealed by comparative analysis of small-subunitribosomal RNA sequence. Lett Appl Microbiol 13: 2026.
  • Beattie SH, Williams AG. 1999. Detection of toxigenic strains of Bacillus cereus and other Bacillus spp. with an improved cytotoxicity assay. Lett Appl Microbiol 28: 2215.
  • Bergey DH, Breed RS, Murray EGD, Parket-Hitchens A. 1939. Bergey's manual of determinative bacteriology. 5th ed. Baltimore : William & Wilkins Co.
  • Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V. 2003. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis. 36: 77580.
  • Caldini G, Trotta F, Cenci G. 2002. Inhibition of 4-nitroquinoline-1-oxide genotoxicity by Bacillus strains. Res Microbiol 153: 16571.
  • Casula G, Cutting SM. 2002. Bacillus probiotics: spore germination in the gastrointestinal tract. Appl Environ Microbiol 68: 234452.
  • Cavazzoni B, Adami A, Castrovilli C. 1998. Performance of broiler chickens supplemented with Bacillus coagulans as probiotic. Brit Poultry Sci. 39: 5269.
  • Ciffo F. 1984. Determination of the spectrum of antibiotic resistance of the Bacillus subtilis strains of Enterogermina. Chemioterapia III(1): 4551.
  • Ciprandi G, Scordamaglia A, Venuti D, Caria M, Canonica GW. 1986. In vitro effects of Bacillus subtilis on the immune response. Chemioterapia V(6): 4047.
  • Collins MD, Jones D. 1979. Isoprenoid quinine composition as a guide to the classification of Sporolactobacillus and possibly related bacteria. J Appl Bacteriol 47: 35660.
  • Czerucka D, Rampal P. 2002. Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4: 7339.
  • De Boer AS, Diderichsen B. 1991. On the safety of Bacillus subtilis and B. amyloliquefaciens: a review. Appl Microbiol Biotechnol 36: 14.
  • Dellaglio F, Bottazzi V, Vescovo M. 1975. Deoxyribonucleic acid homology among Lactobacillus species of the subgenus Streptobacterium Orla-Jensen. Int J Syst Bacteriol 25: 16072.
  • Donohue DC, Deighton M, Ahokas JT, Salminen S. 1993. Toxicity of lactic acid bacteria. In: SalminenS, Von WrightA, editors. Lactic acid bacteria. New York : Marcel Dekker, Inc. p 30713.
  • Donohue DC, Salminen S. 1996. Saferty of probiotic bacteria. Asia Pac J Clin Nutr 5: 258.
  • Doores S, Westhoff DC. 1983. Selective method for the isolation of Sporolactobacillus from food and environmental sources. J Appl Bacteriol 54: 27380.
  • Edwards S, Seddon B. 2001. Mode of antagonism of Brevibacillus brevis against Botrytis cinerea in vitro. J Appl Microbiol 91: 6529.
  • [FAO/WHO] Food and Agriculture Organization/World Health Organization. 2001. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Available from: http://www.fao.org/es/ESN/food/foodandfood_probio_en.stm. Accessed 1 July 2003.
  • Goto N, Maeyama J, Yasuda Y, Isaka M, Matano K, Kozuka S, Taniguchi T, Miura Y, Ohkuma K, Tochikubo K. 2000. Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Vaccine 2000 18: 216471.
  • Green DH, Wakeley PR, Page A, Barnes A, Baccigalupi L, Ricca E, Cutting SM. 1999. Characterization of two Bacillus probiotics. Appl Environ Microbiol 65: 428891.
  • Guarner F, Malagelada JR. 2003. Gut flora in health and disease. Lancet. 361: 5129.
  • Hattori Z, Misawa H, Igarashi I, Sugiya Y. 1965. Effects of lactic acid-forming bacteria on Vibrio comma inoculated into intestinal segments of rabbits. J Bacteriol 90: 5415.
  • Hess A., Hollander R, Mannheim W. 1979. Lipoquinone of spore-forming rods, lactic acid and actyno-mycetes. J Gen Microbiol 115: 247252.
  • Hoa TT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S, Ricca E, Cutting SM. 2000. Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Environ Microbiol 66: 52417.
  • Hoa TT, Duc LH, Isticato R, Baccigalupi L, Ricca E, Van PH, Cutting SM. 2001. Fate and dissemination of Bacillus subtilis spores in a murine model. Appl Environ Microbiol 67: 381923.
  • Horowitz-Wlassowa LM, Nowotelnow NW. 1932. Über eine sporogene Milchsäurebakterienart, Lacto-bacillus sporogenes n. sp. Cent F Bak, II Abt., 87: 331.
  • Hosoi T, Ametani A, Kiuchi K, Kaminogawa S. 1999. Changes in fecal microflora induced by intubation of mice with Bacillus subtilis (natto) spores are dependent upon dietary components. Can J Microbiol 45: 5966.
  • Hosoi T, Ametani A, Kiuchi K, Kaminogawa S. 2000. Improved growth and viability of lactobacilli in the presence of Bacillus subtilis (natto), catalase, or subtilisin. Can J Microbiol 46: 8927.
  • Hosoi T, Kiuchi K. 2003. Natto - A food made by fermenting cooked soybeans with Bacillus subtilis (natto). In: Handbook of Fermented Functional Foods. FarnworthER, editor. Boca Raton , Fla. : CRC Press. p 22745.
  • Hyronimus B, Le Marrec C, Hadj Sassi A, Deschamps A. 2000. Acid and bile tolerance of spore-forming lactic acid bacteria. Int J Food Microbiol 61: 1937.
  • Hyronimus B, Le Marrec C, Urdaci MC. 1998. Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. J Appl Microbiol 85: 4250.
  • Jadamus A, Vahjen W, Simon O. 2001. Growth behaviour of a spore-forming probiotic strain in the gastrointestinal tract of broiler chicken and piglets. Arch Tierernahr 54: 117.
  • Kitahara K, Lai CL. 1967. On the spore formation of Sporolactobacillus inulinus. J Gen Appl Microbiol 13: 97203.
  • Kitahara K, Toyota T. 1972. Auto-spheroplastization in Sporolactobacillus. J Gen Appl Microbiol 18: 99107.
  • Kitahara K., Suzuki J. 1963. Sporolactobacillus Nov. Subgen. J Appl Bacteriol 9: 5971.
  • Koehler TM, Thorne CB. 1987. Bacillus subtilis (natto) plasmid pLS20 mediates interspecies plasmid transfer. J Bacteriol 169: 52718.
  • Kozuka S, Yasuda Y, Isaka M, Masaki N, Taniguchi T, Matano K, Moriyama A, Ohkuma K, Goto N, Udaka S, Tochikubo K. 2000. Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity. Vaccine 18: 17307.
  • Le Marrec C, Hyronimus B, Bressollier P, Verneuil B, Urdaci MC. 2000. Biochemical and genetic characterization of coagulin, a new antilisterial bacteriocin in the pediocin family of bacteriocins, produced by Bacillus coagulans I4. Appl Environ Microbiol 66: 521320.
  • Lee KH, Jun KD, Kim WS, Paik HD. 2001. Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus. Lett Appl Microbiol 32: 146151.
  • Logan NA, Turnbull PCB. 1999. Bacillus and Recently Derived Genera. In: MurrayPR, BaronEJ, PfallerMA, TenoverFC, YolkenRH, editors. Manual of Clinical Microbiology. 7th ed. Washington DC : ASMPress. p 35769.
  • Mazza P, Zani F, Martelli P. 1992. Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy. Boll Chim Farmaceutico 131: 4018.
  • Mazza P. 1994. The use of Bacillus subtilis as an antidiarrhoeal microorganism. Boll Chim Farmaceutico 133: 318.
  • Meroni PL, Palmieri R, Barcellini W, De Bartolo G, Zanussi C. 1983. Effect of long-term treatment with Bacillus subtilis on the frequency of urinary tract infections in older patients. Chemioterapia II(2): 1424.
  • Miyauchi A, Ozawa M, Mizukami M, Yashiro K, Ebisu S, Tojo T, Fujii T, Takagi H. 1999. Structural conversion from non-native to native form of recombinant human epidermal growth factor by Brevibacillus choshinensis. Biosci Biotechnol Biochem 63: 19659.
  • Mohan JC, Arora R, Khalilullah M. 1990a. Preliminary observations on effect of Lactobacillus sporogenes on serum lipid levels in hypercholesterolemic patients. Indian J Med Res. 92: 4312.
  • Mohan JC, Arora R, Khalilullah M. 1990b. Short term hypolipidemic effects of oral Lactobacillus sporogenes therapy in patients with primary dyslipidemias. Ind Heart J 42: 3614.
  • Muscettola M, Grasso G, Blach-Olszewska Z, Migli-accio P, Borghesi-Nicoletti C, Giarrantana M, Gallo VC. 1992. Effects of Bacillus subtilis spores on interferon production. Pharmacological Res 26(Suppl 2): 176177.
  • Nakano MM, Zuber P. 1998. Anaerobic growth of a “strict aerobe” (Bacillus subtilis). Annu Rev Microbiol. 52: 16590.
  • Oggioni MR, Pozzi G, Balensin PE, Galieni P, Bigazzi C. 1998. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 36: 3256.
  • Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F, Urdaci MC. 2001. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrobiol Agents Chemotherapy 45: 315661.
  • Prokešová L, Nováková M, Julák J, Mára M. 1994. Effect of Bacillus firmus and other sporulating aerobic microorganisms on in vitro stimulation of human lymphocytes: a comparative study. Folia Microbiol 39: 5014.
  • Przyrembel H. 2001. Consideration of possible legislation within existing regulatory frameworks. Amer J Clin Nutr 73 (suppl): 471S5S.
  • Reid G, Sanders ME, Gaskins HR, Gibson G, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR. 2003. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol. Forthcoming.
  • Richard V, Auwera P. Snoeck R, Daneau D, Meunier F. 1988. Nosocomial bacteremia caused by Bacillus species. Eur J Clin Microbiol Infect Dis 7: 7835.
  • Rowan NJ, Deans K, Anderson JG, Gemmell CG, Hunter IS, Chaithong T. 2001. Putative virulence factor expression by clinical and food isolates of Bacillus spp. after growth in reconstituted infant milk formulae. Appl Environ Microbiol 67: 387381.
  • Rychen G, Simoes Nunes C. 1993. Effects of a microbial probiotic (Sporolactobacillus P 44) on postprandial porto-arterial concentration differences of glucose, galactose and amino-nitrogen in the growing pig. Reprod Nutr Dev 33: 5319.
  • Rychen G, Simoes Nunes C. 1995. Effects of 3 microbial probiotics on post prandial porto arterial concentration differences of glucose galactose and amino-nitrogen in the young pig. Br J Nutr 74: 1926.
  • Samanya M, Yamauchi KE. 2002. Histological alterations of intestinal villi in chickens fed dried Bacillus subtilis var. natto. Comp Biochem Physiol A Mol Integr Physiol 133: 95104.
  • Sanders ME, Morelli L, Bush S. 2001. “Lactobacillus sporogenes” is not a Lactobacillus probiotic. ASM News 67: 3856.
  • Sarkar PK, Hasenack B, Nout MJ. 2002. Diversity and functionality of Bacillus and related genera isolated from spontaneously fermented soybeans (Indian Kinema) and locust beans (African Soumbala). Int J Food Microbiol 25: 17586.
  • [SCAN] Scientific Committee on Animal Nutrition. 2002a. Report of the Scientific Committee on Animal Nutrition, Opinion of the Scientific Committee on Animal Nutrition on the safety of use of Bacillus species in animal nutrition. European Commission, Health & Consumer Protection Directorate-General.
  • [SCAN] Scientific Committee on Animal Nutrition. 2002b. Report of the Scientific Committee on Animal Nutrition, Opinion of the SCAN on the criteria for assessing the safety of microorganisms resistant to antibiotics of human, clinical, and veterinary importance. European Commission Health & Consumer Protection Directorate-General. http://europa.eu.int/comm/food/fs/sc/scan/out64_en.pdf. Accesses 1 July 2003.
  • Senesi S, Celandroni F, Tavanti A, Ghelardi E. 2001. Molecular characterization and identification of Bacillus clausii strains marketed for use in oral bacteriotherapy. Appl Environ Microbiol 67: 8349.
  • Shida O, Takagi H, Kadowaki K, Komagata K. 1996. Proposal for two new genera, Brevibacillus gen. nov. and Aneurinibacillus gen. nov. Int J Syst Bacteriol 46: 93946.
  • Sneath PHA. 1986. Bergey's manual of systematic bacteriology. Vol 2. Baltimore , Md. : William & Wilkins Co. p 1104.
  • Sorokulova IB, Kirik DL, Pinchuk IV. 1997. Probiotics against Campylobacter pathogens. J Travel Med 4: 16770.
  • Spinosa MR, Braccini T, Ricca E, De Felice M, Morel-li L, Pozzi G, Oggioni MR. 2000a. On the fate of ingested Bacillus spores. Res. Microbiol. 151: 3618.
  • Spinosa MR, Wallet F, Courcol RJ, Oggioni MR. 2000b. The trouble in tracing opportunistic pathogens: cholangitis due to Bacillus in a French hospital caused by a strain related to an Italian probiotic Microb Ecol Health Dis 12: 99101.
  • Tompkins, T. 2002. Unpublished data. Institut Rosell Inc., Montreal, QC, Canada.
  • Uchida K, Mogi K. 1973. Cellular fatty acid spectra of Sporolactobacillus and some other Bacillus-Lac-tobacillus intermediates as a guide to their taxonomy. Vaccine 18: 17307.
  • Vacca A, Pantaleo G, Ronco M, Dammacco F. 1983. Chemoimmunotherapy for multiple myeloma using an intermittent combination drug schedule (Melphalan + Prednisone) and alternating courses of Bacillus subtilis spores. Chemioterapia II(5): 3006.
  • Zahner V, Rabinovitch L, Suffys P, Momen H. 1999. Genotypic diversity among Brevibacillus laterosporus strains. Appl Environ Microbiol 65: 51825.